GSTM1 and myelodysplastic syndrome: Tumors affecting the bone marrow, as seen in myelodysplastic syndromes and leukemia, can disrupt the normal production of RBCs, manifesting as changes in the RDW and Hb levels, ultimately influencing the Hb/RDW ratio [51].